Guangzhou Petrochemical: The annual cost of the micro-oxygen meter transformation is 300,000 yuan
Clinical value orientation makes doctors a part of the pharmaceutical industry chain
Youzhiyou Biotech completes B-2 round of financing for the clinical development of M701 and M802
More than 10 new drugs have been approved for clinical use!
Threshold for oncology drug development is raised: FDA pays attention to clinical trial dose design
Notice on Public Comment on "Guiding Principles for Comprehensive Analysis of Effectiveness of Drug Clinical Research (Draft for Comment)"
Three Stanford scholars receive US$31 million to carry out stem cell clinical trials
Hengrui Class 1 new drug SHR7280 is approved for clinical prevention of premature ovulation
Hansen Pharma submits Phase III clinical trial application for the treatment of mycotic vaginitis
the prognosis of patients with advanced esophageal squamous cell carcinoma: Phase 3 clinical study ESCORT-1st
FDA expands the list of targets for violations for the first time: researchers who fail to report clinical trial results on time will be punished
Dementia breakthrough: oxygen therapy "improves memory and concentration"
Nearly a quarter of patients survived for more than 3 years. Long-term clinical results of BMS dual immunotherapy are positive
JAMA Neurol: The effect of deep brain stimulation of the subthalamic nucleus under general anesthesia on the clinical symptoms of Parkinson's patients
Hebo Pharma's new-generation anti-CTLA-4 antibody HBM4003 was approved for two clinical trials in China
The Lancet Rheumatology: Clinical and molecular characteristics related to the outcome of acute
Chia Tai Tianqing, Hausen, Hengrui...78 new drugs were approved for clinical use, Qilu biologics broke out, and influenza 1 new drugs struck
J Thromb Haemost: The effect of body mass index on the clinical outcome of venous thromboembolism
J Thromb Haemost: The Pregnancy Adaptation Geneva (PAG) Score is used to assess the clinical probability of pulmonary embolism during pregnancy
Obtained FDA Fast Track Qualification, Innovative Inhaled Antibiotic Therapy Reached Phase 3 Clinical Endpoint